Evidence map›Paper›PMID 34627589›Full record

ArticleIndian heart journal

Patent foramen ovale closure in India; Feasibility, challenges and mid-term outcomes.

Viji S Thomson, Sanjith Aaron, Nathaniel Samson D, Jesu Krupa, A T Prabhakar, John Jose, Paul George, Oommen K George, George Joseph, Bijesh Kumar Yadav

Abstract read
In one paragraph

Article in Indian heart journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Viji S ThomsonDepartment of Cardiology, Christian Medical College and Hospital, Vellore, 632004, India. Electronic address: vijisamuel.t@cmcvellore.ac.in.
Sanjith AaronDepartment of Neurology, Christian Medical College and Hospital, Vellore, 632004, India.
Nathaniel Samson DDepartment of Cardiology, Christian Medical College and Hospital, Vellore, 632004, India.
Jesu KrupaDepartment of Cardiology, Christian Medical College and Hospital, Vellore, 632004, India.
A T PrabhakarDepartment of Neurology, Christian Medical College and Hospital, Vellore, 632004, India.
John JoseDepartment of Cardiology, Christian Medical College and Hospital, Vellore, 632004, India.
Paul GeorgeDepartment of Cardiology, Christian Medical College and Hospital, Vellore, 632004, India.
Oommen K GeorgeDepartment of Cardiology, Christian Medical College and Hospital, Vellore, 632004, India.
George JosephDepartment of Cardiology, Christian Medical College and Hospital, Vellore, 632004, India.
Bijesh Kumar YadavDepartment of Biostatistics, Christian Medical College and Hospital, Vellore, 632004, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Patent foramen ovale closure (PFO) is an underutilized therapy, and our study explored the challenges and feasibility of PFO closure in the Indian setting. Eighty patients with Embolic Stroke of Undetermined Source (ESUS) were screened by transcranial Doppler (TCD) for PFO. Twenty-nine patients underwent successful closure. High-risk features of a long tunnel, inter-atrial septal aneurysm, and large defect were present in 31%, 28%, and 59%. Transcranial Doppler had a sensitivity and specificity of 78% and 53% (p = 0.02) to detect PFO. Anticoagulation was withdrawn in 85% of patients post closure. Two patients had residual shunts at follow-up of 19 (9,34) months.

Indexed as

Foramen Ovale, PatentHeart AneurysmSeptal Occluder DeviceStrokeFeasibility StudiesHumansIndiaRecurrenceTreatment OutcomeCryptogenic strokeEmbolic stroke of undetermined source(ESUS)Patent foramen ovale (PFO)

Identifiers

PMID34627589
PMCPMC8514405

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.